Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
about
Cost-effectiveness of augmenting universal hepatitis B vaccination with immunoglobin treatmentEconomic evaluations of vaccines in Canada: a scoping review.Comprehensive control (or elimination) of hepatitis B virus transmission in the United StatesHepatitis B vaccine effectiveness in the face of global HBV genotype diversity.Medical decision analysis in infectious diseases.Hepatitis B immunization in a low-incidence province of Canada: comparing alternative strategies.Cost comparison of recombinant human erythropoietin and blood transfusion in cancer chemotherapy-induced anemia.RECOMMENDATION FOR HEPATITIS - B VACCINATION.Primer on medical decision analysis: Part 4--Analyzing the model and interpreting the results.Costing methods in the Canadian literature on the economic evaluation of health care. A survey and assessment.Immunity to hepatitis B vaccine in Tanzanian under-5 children.The cost effectiveness of hepatitis immunization for US college students.A cost-benefit analysis of gown use in controlling vancomycin-resistant Enterococcus transmission: is it worth the price?An economic evaluation of universal infant vaccination against hepatitis B virus using a combination vaccine (Hib-HepB): a decision analytic approach to cost effectiveness.
P2860
Q33587889-C9C1E886-BE42-40C5-8B07-3C983026DBB2Q33644881-3AADA9CB-2681-4950-954F-BCBD880E50BAQ34441991-DB42A39A-3044-41F2-B64D-AC910C87DE7EQ37956379-43287275-4FED-434F-9EAA-89A1F7586E08Q40662909-9BA18BFE-005B-435A-BDAF-8624556AA3B5Q40880154-C02F6058-A133-44D5-A8C7-317B69F947D2Q40915887-52010D10-2349-4707-9992-E3A904A07358Q41142359-54AE8B5C-D648-4AD5-9E48-2FC36E056424Q41434879-2EB50CE5-3A2F-480E-83E7-E8730C2A9601Q41459368-90CBB7D2-B219-45B6-963E-9FE49B89B9C1Q43941893-0C997375-90DB-4F72-A3A2-EC2067B8B38EQ44864303-7957646B-0952-47BF-8700-BFE9CE6712B1Q44930328-078C4EF8-9318-4084-B9AB-1045B692D726Q45736191-E1A8CA11-6655-4437-BCAF-A19CEBD5007E
P2860
Should Canada and the United States universally vaccinate infants against hepatitis B? A cost-effectiveness analysis.
description
1993 nî lūn-bûn
@nan
1993年の論文
@ja
1993年学术文章
@wuu
1993年学术文章
@zh-cn
1993年学术文章
@zh-hans
1993年学术文章
@zh-my
1993年学术文章
@zh-sg
1993年學術文章
@yue
1993年學術文章
@zh
1993年學術文章
@zh-hant
name
Should Canada and the United S ...... A cost-effectiveness analysis.
@en
Should Canada and the United S ...... A cost-effectiveness analysis.
@nl
type
label
Should Canada and the United S ...... A cost-effectiveness analysis.
@en
Should Canada and the United S ...... A cost-effectiveness analysis.
@nl
prefLabel
Should Canada and the United S ...... A cost-effectiveness analysis.
@en
Should Canada and the United S ...... A cost-effectiveness analysis.
@nl
P2860
P1476
Should Canada and the United S ...... A cost-effectiveness analysis.
@en
P2093
A S Detsky
P2860
P356
10.1177/0272989X9301300103
P50
P577
1993-01-01T00:00:00Z